We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$2.55B
AUM Growth
+$71.7M
Cap. Flow
-$81.9M
Cap. Flow %
-3.21%
Top 10 Hldgs %
5.31%
Holding
1,322
New
211
Increased
334
Reduced
433
Closed
270

Top Buys

Rank Stock Value
1
MATX icon
Matsons
MATX
+$7.54M
2
PK icon
Park Hotels & Resorts
PK
+$6.53M
3
LNTH icon
Lantheus
LNTH
+$6.24M
4
PEGA icon
Pegasystems
PEGA
+$5.99M
5
CNM icon
Core & Main
CNM
+$5.29M

Sector Composition

Rank Sector Weight
1 Industrials 17.54%
2 Technology 15.26%
3 Financials 14.16%
4 Healthcare 13.52%
5 Consumer Discretionary 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWL icon
526
Powell Industries
POWL
$8.83B
$1.39M 0.05%
29,373
+2,373
+9% +$102K
OPLN
527
Openlane
OPLN
$4.13B
$1.39M 0.05%
80,170
-36,270
-31% -$545K
TNDM icon
528
Tandem Diabetes Care
TNDM
$1.16B
$1.39M 0.05%
39,113
+27,970
+251% +$749K
OMCL icon
529
Omnicell
OMCL
$1.81B
$1.38M 0.05%
47,325
+19,950
+73% +$605K
NPKI
530
NPK International
NPKI
$1.22B
$1.37M 0.05%
190,360
+133,750
+236% +$874K
RUSHA icon
531
Rush Enterprises Class A
RUSHA
$5.93B
$1.37M 0.05%
25,658
-177,344
-87% -$8.38M
CERE
532
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.37M 0.05%
32,430
+1,160
+4% +$48.7K
VTOL icon
533
Bristow Group
VTOL
$1.34B
$1.37M 0.05%
50,370
-3,280
-6% -$87.4K
GXO icon
534
GXO Logistics
GXO
$6.05B
$1.37M 0.05%
25,420
JRVR icon
535
James River Group Holdings
JRVR
$209M
$1.37M 0.05%
146,955
+36,889
+34% +$338K
PHIN icon
536
Phinia Inc
PHIN
$2.9B
$1.36M 0.05%
+35,450
New +$1.15M
CGEM icon
537
Cullinan Oncology
CGEM
$1.06B
$1.36M 0.05%
79,680
+38,660
+94% +$597K
CVBF icon
538
CVB Financial
CVBF
$3.95B
$1.36M 0.05%
76,016
-45,270
-37% -$803K
AMRC icon
539
Ameresco
AMRC
$1.25B
$1.35M 0.05%
+55,870
New +$1.25M
MTX icon
540
Minerals Technologies
MTX
$2.27B
$1.33M 0.05%
+17,670
New +$1.24M
VKTX icon
541
Viking Therapeutics
VKTX
$4.11B
$1.33M 0.05%
+16,190
New +$720K
TBBK icon
542
The Bancorp
TBBK
$2.74B
$1.32M 0.05%
39,582
-63,111
-61% -$2.51M
NTB icon
543
Bank of N.T. Butterfield & Son
NTB
$2.39B
$1.32M 0.05%
41,170
+1,360
+3% +$41.4K
IONS icon
544
Ionis Pharmaceuticals
IONS
$9.23B
$1.31M 0.05%
30,242
+12,830
+74% +$612K
LEVI icon
545
Levi Strauss
LEVI
$9.27B
$1.31M 0.05%
+65,570
New +$1.14M
CC icon
546
Chemours
CC
$2.63B
$1.31M 0.05%
49,860
+1,840
+4% +$52.4K
ZUO
547
DELISTED
Zuora, Inc.
ZUO
$1.31M 0.05%
143,260
-118,891
-45% -$1.04M
SAFE
548
Safehold
SAFE
$1.15B
$1.31M 0.05%
63,420
-21,650
-25% -$450K
MTZ icon
549
MasTec
MTZ
$28.4B
$1.3M 0.05%
13,980
-6,340
-31% -$482K
HAIN icon
550
Hain Celestial
HAIN
$49.1M
$1.3M 0.05%
165,736
+119,935
+262% +$1.18M

Similar funds

Algert Global's Q1 2024 Portfolio in Review

As of Q1 2024, Algert Global held 1,322 positions worth $2.55B, up 2.9% from $2.48B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Algert Global withdrew a net $81.9M in Q1 2024, closing 270 positions and reducing 433 holdings. Its most notable exit was Armstrong World Industries, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Algert Global opened a new position in Jones Lang LaSalle worth $5.67M.

  • Algert Global's largest Q1 2024 buy was Jones Lang LaSalle: 29,060 shares worth $5.67M.
  • Algert Global added most to Matsons in Q1 2024, an estimated $7.54M increase.
  • Algert Global's biggest Q1 2024 reduction was Rush Enterprises Class A, cutting an estimated $8.38M.
  • Algert Global fully exited Armstrong World Industries in Q1 2024, selling an estimated $12.9M.
  • Algert Global's ten largest holdings make up 5.3% of its $2.55B portfolio in Q1 2024.
  • Algert Global opened 211 new positions and closed 270 in Q1 2024.
  • Algert Global's portfolio value rose 2.9% quarter-over-quarter to $2.55B.

Based on Algert Global's 13F filing for Q1 2024, filed 15 May 2024.